These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

369 related articles for article (PubMed ID: 15934528)

  • 21. Mail-order sales of drugs without prescriptions under investigation by US, Canadian agencies.
    Spurgeon D
    CMAJ; 1993 Dec; 149(11):1700-1. PubMed ID: 8242510
    [No Abstract]   [Full Text] [Related]  

  • 22. Opening Pandora's pillbox: using modern information tools to improve drug safety.
    Gottlieb S
    Health Aff (Millwood); 2005; 24(4):938-48. PubMed ID: 16012136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Best medicines for less: we compare drugs for what ails America.
    Consum Rep; 2008 Jan; 73(1):27-9. PubMed ID: 18488284
    [No Abstract]   [Full Text] [Related]  

  • 24. Pharmaceuticals and medical devices: FDA oversight.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2009 Jan; ():1-28. PubMed ID: 19297718
    [No Abstract]   [Full Text] [Related]  

  • 25. Drug promotion and scientific exchange. The role of the clinical investigator.
    Kessler DA
    N Engl J Med; 1991 Jul; 325(3):201-3. PubMed ID: 2052064
    [No Abstract]   [Full Text] [Related]  

  • 26. Policy currents. FDA addresses backlog of generic medication applications.
    Consult Pharm; 2006 May; 21(5):419-21. PubMed ID: 16929569
    [No Abstract]   [Full Text] [Related]  

  • 27. Strategy for surveillance of adverse drug events.
    Bright RA
    Food Drug Law J; 2007; 62(3):605-16. PubMed ID: 17915403
    [No Abstract]   [Full Text] [Related]  

  • 28. Validation--how much can the world afford? Are we getting value for money?
    Anisfeld MH
    J Pharm Sci Technol; 1994; 48(1):45-8. PubMed ID: 8004419
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmaceuticals and medical devices: FDA oversight. End-of-year issue brief.
    Chaps NA
    Issue Brief Health Policy Track Serv; 2008 Jan; ():1-18. PubMed ID: 18345557
    [No Abstract]   [Full Text] [Related]  

  • 30. Evaluating drug effects in the post-Vioxx world: there must be a better way.
    Avorn J
    Circulation; 2006 May; 113(18):2173-6. PubMed ID: 16684873
    [No Abstract]   [Full Text] [Related]  

  • 31. Should new drugs be avoided?
    Child Health Alert; 2002 Jun; 20():2. PubMed ID: 12096722
    [No Abstract]   [Full Text] [Related]  

  • 32. What antibiotics have you taken recently?
    Black J
    Plast Surg Nurs; 1996; 16(1):6. PubMed ID: 8710988
    [No Abstract]   [Full Text] [Related]  

  • 33. Cardiovascular safety of drugs not intended for cardiovascular use: need for a new conceptual basis for assessment and approval.
    Borer JS; Pouleur H; Abadie E; Follath F; Wittes J; Pfeffer MA; Pitt B; Zannad F
    Eur Heart J; 2007 Aug; 28(15):1904-9. PubMed ID: 17615083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The resurgence of saccharin.
    Frankel HH
    West J Med; 1993 Aug; 159(2):215-6. PubMed ID: 8212700
    [No Abstract]   [Full Text] [Related]  

  • 35. The drug safety review process.
    Somberg J
    Am J Ther; 2007; 14(2):119. PubMed ID: 17414577
    [No Abstract]   [Full Text] [Related]  

  • 36. High drug costs seem to keep getting higher.
    Ackerman W
    J Ark Med Soc; 2005 Apr; 101(10):293. PubMed ID: 15839313
    [No Abstract]   [Full Text] [Related]  

  • 37. Adverse-drug-reaction monitoring.
    Faich GA
    N Engl J Med; 1986 Jun; 314(24):1589-92. PubMed ID: 3713757
    [No Abstract]   [Full Text] [Related]  

  • 38. Research, regulation and development of new pharmaceuticals: past, present and future. II.
    Lasagna L
    Am J Med Sci; 1972 Feb; 263(2):66-78. PubMed ID: 5017858
    [No Abstract]   [Full Text] [Related]  

  • 39. Blame Canada. New Hampshire will defy the FDA and buy drugs on the Net.
    Gupta S
    Time; 2003 Dec; 162(25):130. PubMed ID: 14712612
    [No Abstract]   [Full Text] [Related]  

  • 40. Pharmacists and postmarketing restriction of drug products.
    Zellmer WA
    Am J Hosp Pharm; 1992 Jul; 49(7):1677. PubMed ID: 1621721
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.